Detalhe da pesquisa
1.
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
Cancer
; 129(2): 264-271, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420773
2.
Physician Awareness of Immune-Related Adverse Events of Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 20(12): 1316-1320, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509071
3.
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
Cancer
; 126(19): 4353-4361, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32697352